Results 211 to 220 of about 1,804,103 (360)

Effect of Promoter LA2O3 on NI/AL2O3 Catalysts in the Steam Reforming of Volatiles Derived from Biomass Pyrolysis

, 2017
Laura Santamaria, Gartzen López, Maider Amutio, Maite Artetxe, Jon Álvarez, Itsaso Barbarias, A. Arregi, Martı́n Olazar   +7 more
openalex   +1 more source

Comparative Efficacy of an Organic Acid Blend and Bacitracin Methylene Disalicylate as Growth Promoters in Broiler Chickens: Effects on Performance, Gut Histology, and Small Intestinal Milieu [PDF]

, 2009
Saikat Samanta, S. Haldar, T. K. Ghosh
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Identification of a GA-Related <i>Cis</i>-Element Regulating Male Peduncle Elongation in Papaya. [PDF]

Plants (Basel)
Nguyen-Edquilang J, Yue J, Ming R.
europepmc   +1 more source

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis [PDF]

, 2007
Inga Peters, Kristina Rehmet, Nadine Wilke, Markus A. Kuczyk, Jörg Hennenlotter, Tyark Eilers, S. Machtens, Udo Jonas, Jürgen Serth   +8 more
openalex   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Silencing of optogenetic and chemogenetic transgenes in human iPSCs involves promoter methylation and methylation-independent mechanisms. [PDF]

Epigenetics
Wang Y, Li Y, Li J, Li M, Qiu X.
europepmc   +1 more source

Author response: The nucleosomal barrier to promoter escape by RNA polymerase II is overcome by the chromatin remodeler Chd1

, 2014
Peter J. Skene, Aaron E Hernandez, Mark Groudine, Steven Henikoff   +3 more
openalex   +1 more source

Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters [PDF]

, 2011
Frank Cichocki, Jeffrey S. Miller, Stephen K. Anderson   +2 more
openalex   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source